A Randomized, Open-Label Clinical Trial of Tasisulam Sodium Versus Paclitaxel as Second-Line Treatment in Patients With Metastatic Melanoma

DSpace Repository

A Randomized, Open-Label Clinical Trial of Tasisulam Sodium Versus Paclitaxel as Second-Line Treatment in Patients With Metastatic Melanoma

Author: Hamid, Omid; Ilaria, Robert, Jr.; Garbe, Claus; Wolter, Pascal; Maio, Michele; Hutson, Thomas E.; Arance, Ana; Lorigan, Paul; Lee, Jeeyun; Hauschild, Axel; Mohr, Peter; Hahka-Kemppinen, Marjo; Kaiser, Christopher; Turner, P. Kellie; Conti, Ilaria; Grob, Jean-Jacques
Tübinger Autor(en):
Garbe, Claus
Published in: Cancer (2014), Bd. 120, H. 13, S. 2016-2024
Verlagsangabe: Wiley - Blackwell
Language: English
Full text: http://dx.doi.org/10.1002/cncr.28635
ISSN: 0008-543X
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)